Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
about
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.In vitro efficacy of disinfectants utilised for skin decolonization and environmental decontamination during a hospital outbreak with Candida auris.Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.Candida auris: a worrisome, globally emerging pathogen.Candidiasis and the impact of flow cytometry on antifungal drug discovery.Fungal fatal attraction: a mechanistic review on targeting liposomal amphotericin B (AmBisome®) to the fungal membrane.Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.Candida auris: An Emerging Fungal Pathogen.Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen.The Interface between Fungal Biofilms and Innate Immunity.The Candida auris Alert: Facts and Perspectives.Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All.Candida auris: a Review of the Literature.Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.Containment strategies to address the expanding threat of multidrug-resistant Candida auris.Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention.Candida auris: Disinfectants and Implications for Infection Control.First reported case of multidrug-resistant Candida auris in Canada.Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance.Candida auris in South Africa, 2012-2016Epidemiology, clinical characteristics, resistance, and treatment of infections by
P2860
Q33704302-04107916-73FA-4952-8337-739849A1A079Q39092094-DEB56441-7CF3-43C2-AB07-91B2E9C5D369Q39092240-74356C9B-9077-4B21-800C-2041A65199FFQ39092282-73BD5B9E-AB12-461E-9272-3948135E668CQ40064579-C5EF573C-A539-41D7-AC94-A5B3E9CF6BCBQ40095029-3588B5CF-91D6-47C4-9C05-4365FEE1A6F6Q40127642-B91310A7-042A-42CC-B2F6-4AF9B3683C5CQ46255772-EA287CFD-3672-49B9-BDA0-D50ED34949C6Q46257698-73B5FB2F-D6CB-48B7-BA8F-A6BBB5BD0757Q48220845-3665664B-0D91-42F0-9EFB-9C839491FF72Q49203638-DF556E19-C26F-4833-AC81-CCF69BFD667DQ49489254-7F06808B-5991-490D-A921-52FBDAF6D7A2Q49679927-333DD62F-3E00-4500-8658-AB667D1B2F27Q49988058-D6A12036-61ED-45A0-A72F-648F158969A9Q50065359-21959A1F-B09F-4387-AE37-A742913C1F32Q50128552-3150CFA3-62A8-467C-B98B-9486A9616424Q51782681-02A4B4DE-9237-45CE-95A8-DB0C1D9D2D0BQ53690366-B8AC4908-EDDA-4C07-9B21-D8885D080A08Q55017741-E7A22F42-092A-4F4E-AD17-A5333A594BC7Q55689919-E70D1089-EAED-4343-BE7E-A4FFD41A28CEQ58550566-A6A9B5ED-8743-4C09-A8EF-4C72E3A34ECDQ58598193-D0C06368-7E6E-4DB8-8A6C-61377C6250AD
P2860
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
@en
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
@nl
type
label
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
@en
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
@nl
prefLabel
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
@en
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
@nl
P2093
P2860
P921
P356
P1476
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
@en
P2093
Elizabeth M Johnson
Gordon Ramage
Leighann Sherry
Riina Rautemaa-Richardson
P2860
P304
P356
10.3201/EID2302.161320
P577
2017-02-01T00:00:00Z